Sun Pharma Jul-Sept PAT beats estimates
This story was originally published at 15:03 IST on 28 October 2024
Register to read our real-time news.MUMBAI - Sun Pharmaceutical Industries Ltd.'s consolidated net profit for the September quarter managed to surpass analysts' expectations by a whisker. The drugmaker's consolidated net profit came in at INR 30.40 billion, against the average of INR 29.47 billion estimated by 12 brokerage houses. Its net sales for Jul-Sept rose to INR 132.91 billion against INR 121.92 billion reported a year ago
--Sun Pharma Jul-Sept consol net profit INR 30.40 bln
--Analysts saw Sun Pharma Jul-Sept consol net profit INR 29.47 bln
--Sun Pharma Jul-Sept consol net profit INR 30.40 bln vs INR 23.76 bln
--Sun Pharma Jul-Sept consol revenue INR 132.91 bln vs INR 121.92 bln
--Sun Pharma Apr-Sept consol net profit INR 58.76 bln vs INR 43.98 bln
--Sun Pharma Apr-Sept consol revenue INR 259.44 bln vs INR 241.33 bln
To read more please subscribe
Share this Story:
